Lexaria Bioscience (LEXX) Income from Non-Controlling Interests (2014 - 2026)
Lexaria Bioscience (LEXX) posted Income from Non-Controlling Interests of -$1,779 for fiscal Q3 2026 (quarter ended May 31, 2026), compared with -$1,514 a year earlier.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Income from Non-Controlling Interests (2014 - 2026) Analysis & Trends
For the trailing twelve months through May 31, 2026, Income from Non-Controlling Interests at Lexaria Bioscience was -$8,418; for FY2025 (ended Aug 31, 2025), it was -$9,593.
- In prior fiscal years, Lexaria Bioscience's Income from Non-Controlling Interests was -$13,309 in FY2024, -$47,626 in FY2023, -$114,329 in FY2022 and -$159,142 in FY2021.
- Quarterly Income from Non-Controlling Interests has run from a low of -$124,573 in fiscal Q4 2021 to a high of -$1,390 in fiscal Q4 2025 over five years.
- According to Business Quant data, Income from Non-Controlling Interests for the three prior fiscal quarters was -$2,753 (Q2 2026), -$2,496 (Q1 2026) and -$1,390 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 10.00 Mn |
| 10 | Lexaria Bioscience | 3.04 Mn | -12.61 Mn | - | -1,779.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -1,779.00 |
| Feb 28, 2026 | -2,753.00 |
| Nov 30, 2025 | -2,496.00 |
| Aug 31, 2025 | -1,390.00 |
| May 31, 2025 | -1,514.00 |
| Feb 28, 2025 | -3,760.00 |
| Nov 30, 2024 | -2,929.00 |
| Aug 31, 2024 | -1,781.00 |
| May 31, 2024 | -2,619.00 |
| Feb 29, 2024 | -3,194.00 |
| Nov 30, 2023 | -5,715.00 |
| Aug 31, 2023 | -9,696.00 |
| May 31, 2023 | -12,061.00 |
| Feb 28, 2023 | -12,507.00 |
| Nov 30, 2022 | -13,362.00 |
| Aug 31, 2022 | -45,696.00 |
| May 31, 2022 | -35,413.00 |
| Feb 28, 2022 | -22,895.00 |
| Nov 30, 2021 | -10,325.00 |
| Aug 31, 2021 | -124,573.00 |
API Access
Lexaria Bioscience Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();